Based on SEC filing data. A biotech corporation based in New York raised $2.4M in a Series A convertible note round. The company is in early-stage development with institutional backing.
Get notified the moment Novita Pharmaceuticals, Inc. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.